Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

Authors

Lawrence Corey

Published

March 17, 2021

Abstract

Whether a broadly neutralizing antibody (bnAb) can be used to prevent human immunodeficiency virus type 1 (HIV-1) acquisition is unclear.

Supporters

Support the authors with ResearchCoin

Journal

New England Journal of Medicine

Topics

DOI

10.1056/nejmoa2031738

Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

Authors

Lawrence Corey

Published

March 17, 2021

Abstract

Whether a broadly neutralizing antibody (bnAb) can be used to prevent human immunodeficiency virus type 1 (HIV-1) acquisition is unclear.

Supporters

Support the authors with ResearchCoin

Journal

New England Journal of Medicine

Topics

DOI

10.1056/nejmoa2031738

Paper

Paper

Paper

Paper

Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

Abstract

Supporters

Journal

Topics

DOI

Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

Abstract

Supporters

Journal

Topics

DOI